Radius Health Raises $91M for Osteoporosis Phase III Trial
By Tom Wall
Wednesday, May 25, 2011
Radius Health Inc. raised $91 million $66 million in equity financing and a $25 million term loan facility primarily for a Phase III trial of lead candidate BA058 for the treatment of osteoporosis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.